课题基金 / 基金详情

BIOMARKERS OF HOMEOPATHY IN FIBROMYALGIA

BIOMARKERS OF HOMEOPATHY IN FIBROMYALGIA
纤维肌痛顺势疗法的生物标志物
批准号:
6449750
负责人:
IRIS Roberta BELL
金额:
$0.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2002-05-31

项目摘要

项目成果

IRIS Roberta BELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from Applicant's Abstract): Clinical researchers have not yet demonstrated therapeutic effectiveness of any single intervention that can target the polysymptomatic nature of FM, a chronic debilitating nonarticular rheumatic disorder. Classical homeopathy, a controversial alternative therapy, claims to provide such an integrative intervention to treat the totality of symptoms. This revised R21, 2-year exploratory effectiveness study will involve a 3-month parallel group (N=60), randomized, placebo-controlled, double-blind clinical trial, with an additional 3-month optional crossover, double-blind trial of individualized homeopathic treatment of FM. We will use self-report questionnaires, tender point examinations, and physiological markers of response to the homeopathic remedies and placebo (i.e., EEG alpha activity and orthostatic HRV. Specific aims and hypotheses are: 1) to evaluate the effectiveness of individually-chosen homeopathic treatment for the mental, emotional and somatic symptomatology of FM under double-blind conditions in which active and placebo-treated groups receive the same amount of attention using the same treatment procedures and differ only in the contents of the dispensed drug vials. The investigators hypothesize that individually chosen homeopathic remedies will lead to improvement in spiritual, mental, emotional, and somatic symptoms of FM than will placebo; 2) to determine the ability of acute changes in EEG alpha activity to differentiate active from placebo homeopathic remedies upon olfactory administration in FM patients and to predict subsequent responders and non-responders to treatment. The prediction is that active homeopathic remedies will lead to greater EEG alpha blocking than placebo; and 3) to assess resting EEG alpha power and orthostatic HRV as markers of global clinical improvement in FM over time. Global clinical improvement in FM will correlate with parallel improvements in resting EEG and orthostatic HRV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dilution and Succussion in Homepathic Remedy Dose-Response Patterns
  • 批准号:
    7144840
  • 项目类别:
  • 资助金额:
    $22.65万
  • 财政年份:
    2006
  • 负责人:
    IRIS Roberta BELL
  • 依托单位:
Dilution and Succussion in Homepathic Remedy Dose-Response Patterns
  • 批准号:
    7481050
  • 项目类别:
  • 资助金额:
    $17.96万
  • 财政年份:
    2006
  • 负责人:
    IRIS Roberta BELL
  • 依托单位:
Dilution and Succussion in Homepathic Remedy Dose-Response Patterns
  • 批准号:
    7295693
  • 项目类别:
  • 资助金额:
    $18.51万
  • 财政年份:
    2006
  • 负责人:
    IRIS Roberta BELL
  • 依托单位:
Polysomnography in Homeopathic Remedy Effects
  • 批准号:
    6866104
  • 项目类别:
  • 资助金额:
    $21.57万
  • 财政年份:
    2005
  • 负责人:
    IRIS Roberta BELL
  • 依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    周雄辉
  • 依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2011
  • 负责人:
    颜桥
  • 依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2006
  • 负责人:
    陆豪杰
  • 依托单位: